KNOW THE EFFECT OF ZINC SUPPLEMENT TAKEN ON REGULAR BASES IN CHILDREN SUDDEN RESPIRATORY INFECTIONS by Dr Sadaf Ibrahim, Rubab Zahra, Fayzan Farooq
IAJPS 2019, 06 (05), 8987-8991                     Sadaf Ibrahim et al                     ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 8987 
 
        CODEN [USA]: IAJPBB                        ISSN: 2349-7750 
 
  INDO AMERICAN JOURNAL OF 
 PHARMACEUTICAL SCIENCES 
                              
Available online at: http://www.iajps.com                                  Research Article 
KNOW THE EFFECT OF ZINC SUPPLEMENT TAKEN ON REGULAR 
BASES IN CHILDREN SUDDEN RESPIRATORY INFECTIONS 
1Dr Sadaf Ibrahim, 2Rubab Zahra, 3Fayzan Farooq 
1Major Shabbir Sharif Shaheed Hospital, Kunjah, Gujrat, 2Mayo Hospital Lahore, 3DHQ Teaching 
Hospital Sargodha. 
Abstract: 
Background: In developing world, zinc deficiency is usual among children. Mucosa, immune system and cellular 
metabolism find important role of zinc in them.  
Objective: This study aims to know the effect of zinc supplement taken on regular bases in children sudden respiratory 
infections.  
Design of study: It was a Quasi experimental study. 
Place and duration: This study was done in Services Hospital Lahore from Feb, 2018 to Jan 2019.  
Patients and Methods: For study, 220 children ranging from 6 months up to year of age were selected. These children 
were with complain of cough and fever. For the period of one year, these children are followed up. Days and episodes 
number with critical lower respiratory infection as cough, and 
1: increased respiratory rate  
2: lower chest in drawing existence or temperature > 101F were calculated. There were two groups, A and B in which 
patients were divided. In each group, there were 110 patients. To groups A patient, zinc supplement was given for 3 
months with 10mg/day dosage oral. Oral zinc supplements were not given to group B patients. For critical respiratory 
infections, children in both groups were given ordinary treatment in hospital. A child having medium infection was 
treated at home with anti-biotic and regular follow up for 3 days. In both groups, episodes number of severe 
respiratory tract infection in one year was calculated and then compared. Illness duration and death race was also 
determined.  
Result: In group A, mean illness duration was 3.4+_0.113 days. In group B, 5.1+_0.254 days was mean illness 
duration. In group A, 34 were total number of episodes of respiratory tract infection. Severe respiratory infection had 
78 episodes in group B. recovery rate of patients was 100%. 
Conclusion: Number of episodes of respiratory tract infection were decreased in children taking oral zinc 
supplements on regular basis and it also showed decline in illness duration.  
Keywords: Effect, zinc supplement, regular bases, children, sudden respiratory infections. 
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INTRODUCTION: 
Pneumonia is an infection that inflames the air sacs in 
one or both lungs. Mostly microorganisms are 
causative of pneumonia. In less than 5 year children, it 
is marked cause of medical problems and deaths. 
Estimation of 146-159 million per year new 
pneumonia episodes are reported in developing world 
[1,2] Insufficient food intake, high intake of animal 
food are usual causes of zinc deficiency in children of 
developing nations. Zinc has important role in immune 
system, mucosa and cellular metabolism [3]. 
Reduction in disease and illness duration was reported 
at the rate of 30% with use of zinc. In hospital stay, 
there was 25% reduction [4]. Studies in India have 
shown decrease in respiratory infections in children 
using zinc supplements [5]. In children’s, adjunct 
therapy including 20mg zinc per day speeds up 
recovery from critical pneumonia. It was reported by 
an Indian study that 68% decrease in death rate was 
found to be occurred in SGA infants who were given 
zinc supplements 1-9 months of age [7].  
 
Children suffering from pneumonia have shown lower 
blood zinc levels as compared to healthy ones [8,9,10]. 
In developing countries, it has been described that 
intake of zinc supplements for more than 3 months 
positively reduces respiratory tract infections duration 
in children [11-16]. Assessment of range of 
supplementation has also been done. It is evaluated 
that zinc supplementation should be from 15mg to 140 
mg per week with upper range exceeding 2mg per days 
for less the year children and up to 7 mg/ per day for 
1-3 years’ age children [17,18]. 
 
PATIENTS AND METHODS: 
Total 220 children of 6 months up to 5 years of age 
were selected for study. There was complain of cough 
and fever in these children. These children were 
followed for one year. Days and episodes number with 
critical lower tract respiratory infection as cough and 
rise in respiration rate or 2 lower chests in drawing 
existence or temperature > 101F, were calculated. 
Group A and group B were made. There were 110 
patients in each groups. To group A patient, zinc 
supplement was given for 3 months with 10mg/days 
dosage orally. In both groups, episodes number of 
severe respiratory infection in one year, were 
calculated and then comparison was done. Illness 
duration and death rate was also determined. Chi-
square test was used for comparison of cat goral 
variables between the two groups. T test was used for 
the comparison of mean. A-P value of < 0.05 was 
taken important. Using SPSS 15 version, data was 
analyzed.  
 
RESULTS: 
In group A, mean illness duration was 3.4+_0.113 
days. In group B, 5.1+_0.254 days was mean illness 
duration. 
 
Table No. I: Summary of effect of zinc in children with acute respiratory infection. (N = 220) 
 Group A 
(Oral zinc 
given) 
(n=110)  
Group B 
(no oral zinc 
given) 
(n=110) 
P-
Value 
Duration 
of illness 
3.4 days   
5.1 days 
0.001 
Need to 
change 
antibiotics 
3 (2.7%) 
  
18 (16%) - 
Complicati 
ons 
2 (1.8%) 13 (11.8%) - 
Deaths 0% 0% - 
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In group A, 34 were total number of episodes of 
respiratory tract infection. Critical respiratory 
infection had 78 episodes in group B. recovery rate of 
patient was 100%. Cough and fever was the common 
complain of all patients. From group A only 2 patients 
showed severe respiratory infection complication and 
serious condition after microbial presence in blood, 
after 5 days’ treatment. Only 13 patients from group B 
showed respiratory infection and serious conditions 
after microbial invasion in blood. This happened after 
four days of treatment. During every episodes of 
respiratory infection, Amikacin and Ceftriaxone were 
given to all patients included in both groups. 
 
Table II:  Effect of zinc on episodes of acute respiratory infection.  (N=220) 
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Deaths Complicati ons Need to change antibiotics Poly. (Need to change antibiotics)
 
Group A 
(Oral zinc 
given) 
(n=110) 
 Group B   
(no oral zinc 
given) 
(n=110) 
P-
Value   
Total no. of 
episodes of 
acute 
respiratory 
infection 
during one 
year. 
34 
  
  
78 
  0.02 
Total no. of 
admissions in   
hospital during 
one  
year   
  
6 (5.4%) 
  
33 (30.9%) 
- 
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Table III: Comparison of both groups (N=220) 
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Group A 
(Oral zinc given) 
(n=110) 
Group B  
(no oral zinc 
given)   
(n=110) 
Males                          
                          
82(74.5%) 
 
82(74.5%) 
Females  28(25.4%)            
     28(25.4%) 
Mean age   1.2 years                  1.2 years 
Clinical features dur ing episode of acute respiratory 
infection  
 Fast breathing            100%                  100%             
Nutritional status   
Cough 100%                  100%                    
Malnourished 0%                   0%                   
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DISCUSSION: 
The current study showed beneficial effect of zinc 
supplement in children suffering from severe 
respiratory infection. It decreased number of episodes 
and illness duration. Many studies in Bangladesh, 
India and European countries have demonstrated 
positive effect of use of zinc supplement during 
Pneumonia. In 2004, a study in India has shown 
decreased blood zinc level in children suffering from 
critical pneumonia [3]. Mahalanabis demonstrated 
decline in illness duration by the use of antibiotic along 
with oral zinc supplements. In hospital stay, 25% mean 
reduction was noted in children with pneumonia [4] 
Theodore described that there was enhancement in 
patient’s immunity against microbe’s causative of 
pneumonia in children by the use of oral zinc 
supplements [1]. Brooks demonstrated the 
acceleration in recovery by the adjust therapy with 
20mg zinc per day, in children with pneumonia [6]. 
Improved immunity, rise in growth, decrease and 
death rate decline has been displayed by black [7]. 
Bhavnagar has described that oral zinc supplements in 
addition to enhancement of immunity, prevent sound 
attack of pneumonia in children [9]. Sozawal exhibited 
that zinc supplements reduces prevalence of critical 
lower respiratory tract infections in preschool children 
and infants [10]. Khan F and colleagues had 
demonstrated that less antibiotics dose help in quick 
recovery of children with pneumonia [13]. It has been 
exhibited by some studies that complication chances 
are reduced with oral zinc supplements due to 
increased immunity in children against infections 
[11,12,19].  
 
CONCLUSION: 
Number of episode of respiratory infection were 
decreased in children taking zinc supplements on 
regular basis. It also exhibited reduction in illness 
duration and hospital stay. 
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